Evidence map›Paper›PMID 37345045›Full record

ArticleCancers2023

Sex-Specific Associations of

Sarah V Ward, Isidora Autuori, Li Luo, Emily LaPilla, Sarah Yoo, Ajay Sharma, Klaus J Busam, David W Olilla, Terence Dwyer, Hoda Anton-Culver and 11 more

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Genetic Variations inCancers · 2025
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 9 institutions in 5 countries.

Sarah V WardMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Isidora AutuoriMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Li LuoDepartment of Internal Medicine, The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87106, USA.ORCID 0000-0003-0728-8628
Emily LaPillaMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Sarah YooMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Ajay SharmaMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Klaus J BusamMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
David W OlillaLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.
Terence DwyerClinical Sciences Theme, Heart Group, Murdoch Children's Research Institute, Melbourne, VIC 3052, Australia.ORCID 0000-0002-2091-7663
Hoda Anton-CulverDepartment of Medicine, University of California, Irvine, CA 92617, USA.
Roberto ZanettiPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Lidia SacchettoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.
Anne E CustThe Daffodil Centre, The University of Sydney, A Joint Venture with Cancer Council NSW, Sydney, NSW 2006, Australia.ORCID 0000-0002-5331-6370
Richard P GallagherBC Cancer Research Institute, Vancouver, BC V5Z 1L3, Canada.
Peter A KanetskyDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.ORCID 0000-0002-5567-9618
Stefano RossoPiedmont Cancer Registry, Centre for Epidemiology and Prevention in Oncology in Piedmont, 10126 Turin, Italy.ORCID 0000-0001-6816-2661
Colin B BeggMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Marianne BerwickDepartment of Internal Medicine, The University of New Mexico Comprehensive Cancer Center, Albuquerque, NM 87106, USA.
Nancy E ThomasLineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27514, USA.
Irene OrlowMemorial Sloan Kettering Cancer Center, New York, NY 10065, USA.ORCID 0000-0001-6234-6961
GEM Study Group
Memorial Sloan Kettering Cancer Center · USPiedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of New Mexico · USUniversity of North Carolina at Chapel Hill · USMoffitt Cancer Center · USThe University of Sydney · AUUniversity of British Columbia · CAUniversity of California, Irvine · USUniversity of Tasmania · AU

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI SELWYN M VICKERS · 1985 to 2026
$347.4M
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Sex Differences in Methylome Alterations and Mutational Burden in Early Stage MelanomaP01CA206980 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI BERWICK, MARIANNE, THOMAS, NANCY E. · 2017 to 2022
$10.1M
Melanoma RAS/BRAF Mutation:Heterogeneity-Risk-PrognosisR01CA112243 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI THOMAS, NANCY E. · 2005 to 2014
$5.4M
A MODEL FOR GENETIC SUSCEPTIBILITY: MELANOMAU01CA083180 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 1999 to 2003
$5.2M
Identification of Lethal Melanomas at the Time of DiagnosisR01CA233524 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANTON-CULVER, HODA A, BEGG, COLIN B · 2020 to 2024
$4.5M
Solar Exposure and Melanoma SurvivalR01CA112524 · NCI · UNIVERSITY OF NEW MEXICO · PI BERWICK, MARIANNE · 2005 to 2009
$2.5M
Epidemiologic Parameters of Rare Cancer Risk FactorsR01CA098438 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BEGG, COLIN B · 2003 to 2005
$839k
Validation of the use of whole-genome amplified DNA in a population-based studyR03CA173806 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2013 to 2014
$170k
Mutational Analysis of Clonality in Multiple Primary MelanomaR03CA125829 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ORLOW, IRENE · 2006 to 2007
$128k
NCI NIH HHS P01 CA206980NCI NIH HHS P01CA206980NCI NIH HHS P30118100-15NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016086NCI NIH HHS P30CA016086NCI NIH HHS R01 CA098438NCI NIH HHS R01CA098438NCI NIH HHS R01 CA112243NCI NIH HHS R01CA112243NCI NIH HHS R01 CA112524NCI NIH HHS R01CA112524NCI NIH HHS R01 CA233524NCI NIH HHS R01CA233524NCI NIH HHS R03 CA125829NCI NIH HHS R03CA125829NCI NIH HHS R03 CA173806NCI NIH HHS R03CA173806NCI NIH HHS U01 CA083180NCI NIH HHS U01CA83180
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

estrogen-receptorfunctionalgeneMDM2MDM4melanomapolymorphismrisksexsurvival

Identifiers

PMID37345045
PMCPMC10216616
OpenAlexW4381598362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.